Evidence map›Paper›PMID 38978225›Full record

ArticleCancer biology & therapy2024

BRG1 promotes liver cancer cell proliferation and metastasis by enhancing mitochondrial function and ATP5A1 synthesis through TOMM40.

Yongfeng Hui, Junzhi Leng, Dong Jin, Genwang Wang, Kejun Liu, Yang Bu, Qi Wang

Abstract read
In one paragraph

Article in Cancer biology & therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yongfeng HuiDepartment of Hepatobiliary Surgery, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Junzhi LengDepartment of Hepatobiliary Surgery, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Dong JinDepartment of Hepatobiliary Surgery, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Genwang WangDepartment of Hepatobiliary Surgery, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Kejun LiuDepartment of Hepatobiliary Surgery, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Yang BuDepartment of Hepatobiliary Surgery, Ningxia Medical University, Yinchuan, Ningxia, China.ORCID 0000-0003-0303-5607
Qi WangDepartment of Hepatobiliary Surgery, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) is one of the most lethal malignant tumors worldwide. Brahma-related gene 1 (BRG1), as a catalytic ATPase, is a major regulator of gene expression and is known to mutate and overexpress in HCC. The purpose of this study was to investigate the mechanism of action of BRG1 in HCC cells. In our study, BRG1 was silenced or overexpressed in human HCC cell lines. Transwell and wound healing assays were used to analyze cell invasiveness and migration. Mitochondrial membrane potential (MMP) and mitochondrial permeability transition pore (mPTP) detection were used to evaluate mitochondrial function in HCC cells. Colony formation and cell apoptosis assays were used to evaluate the effect of BRG1/TOMM40/ATP5A1 on HCC cell proliferation and apoptosis/death. Immunocytochemistry (ICC), immunofluorescence (IF) staining and western blot analysis were used to determine the effect of BRG1 on TOMM40, ATP5A1 pathway in HCC cells. As a result, knockdown of BRG1 significantly inhibited cell proliferation and invasion, promoted apoptosis in HCC cells, whereas BRG1 overexpression reversed the above effects. Overexpression of BRG1 can up-regulate MMP level, inhibit mPTP opening and activate TOMM40, ATP5A1 expression. Our results suggest that BRG1, as an oncogene, promotes HCC progression by regulating TOMM40 affecting mitochondrial function and ATP5A1 synthesis. Targeting BRG1 may represent a new and effective way to prevent HCC development.

Indexed as

ApoptosisCarcinoma, HepatocellularCell ProliferationDNA HelicasesLiver NeoplasmsMitochondriaMitochondrial Precursor Protein Import Complex ProteinsNuclear ProteinsTranscription FactorsCell Line, TumorCell MovementGene Expression Regulation, NeoplasticHumansMembrane Potential, MitochondrialMitochondrial Membrane Transport ProteinsMitochondrial Proton-Translocating ATPasesATP5F1A protein, humanDNA HelicasesMitochondrial Membrane Transport ProteinsMitochondrial Precursor Protein Import Complex ProteinsMitochondrial Proton-Translocating ATPasesNuclear ProteinsSMARCA4 protein, humanTOMM40 protein, humanTranscription FactorsBRG1hepatocellular carcinomainvasionproliferationTOMM40

Identifiers

PMID38978225
PMCPMC11236295

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.